Literature DB >> 23509153

Human primary intestinal epithelial cells as an improved in vitro model for Cryptosporidium parvum infection.

Alejandro Castellanos-Gonzalez1, Miguel M Cabada, Joan Nichols, Guillermo Gomez, A Clinton White.   

Abstract

The study of human intestinal pathogens has been limited by the lack of methods for the long-term culture of primary human intestinal epithelial cells (PECs). The development of infection models with PECs would allow a better understanding of host-parasite interactions. The objective of this study was to develop a novel method for prolonged in vitro cultivation of PECs that can be used to study Cryptosporidium infection. We isolated intact crypts from human intestines removed during weight loss surgery. The fragments of intestinal layers were cultivated with culture medium supplemented with growth factors and antiapoptotic molecules. After 7 days, the PECs formed self-regenerating cell clusters, forming villi that resemble intestinal epithelium. The PECs proliferated and remained viable for at least 60 days. The cells expressed markers for intestinal stem cells, epithelial cells, and mature enterocytes. The PECs were infected with Cryptosporidium. In contrast to older models in which parasite numbers decay, the burden of parasites increased for >120 h. In summary, we describe here a novel method for the cultivation of self-regenerating human epithelial cells from small intestinal crypts, which contain both intestinal stem cells and mature villus cells. We present data that suggest these cells support Cryptosporidium better than existing cell lines. PECs should provide an improved tool for studying host-parasite interactions involving Cryptosporidium and other intestinal pathogens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23509153      PMCID: PMC3676030          DOI: 10.1128/IAI.01131-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Mammalian intestinal epithelial cells in primary culture: a mini-review.

Authors:  Bertrand Kaeffer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-03       Impact factor: 2.416

2.  A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage.

Authors:  Fabio Tosini; Alessia Agnoli; Raffaella Mele; Maria Angeles Gomez Morales; Edoardo Pozio
Journal:  Mol Biochem Parasitol       Date:  2004-03       Impact factor: 1.759

Review 3.  Evolution of Cryptosporidium in vitro culture.

Authors:  P Karanis; H M Aldeyarbi
Journal:  Int J Parasitol       Date:  2011-08-22       Impact factor: 3.981

4.  Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro.

Authors:  Xiaomin Cai; Keith M Woods; Steve J Upton; Guan Zhu
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines.

Authors:  S J Upton; M Tilley; D B Brillhart
Journal:  FEMS Microbiol Lett       Date:  1994-05-15       Impact factor: 2.742

6.  Cryptosporidium infection of human intestinal epithelial cells increases expression of osteoprotegerin: a novel mechanism for evasion of host defenses.

Authors:  Alejandro Castellanos-Gonzalez; Linda S Yancey; Heuy-Ching Wang; Birte Pantenburg; Kathleen R Liscum; Dorothy E Lewis; A Clinton White
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

7.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

Review 8.  Host intestinal epithelial response to Cryptosporidium parvum.

Authors:  Mingqi Deng; Mark S Rutherford; Mitchell S Abrahamsen
Journal:  Adv Drug Deliv Rev       Date:  2004-04-19       Impact factor: 15.470

9.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

10.  Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.

Authors:  Jason R Spence; Christopher N Mayhew; Scott A Rankin; Matthew F Kuhar; Jefferson E Vallance; Kathryn Tolle; Elizabeth E Hoskins; Vladimir V Kalinichenko; Susanne I Wells; Aaron M Zorn; Noah F Shroyer; James M Wells
Journal:  Nature       Date:  2010-12-12       Impact factor: 49.962

View more
  27 in total

1.  Quantitative analysis of Cryptosporidium growth in in vitro culture--the impact of parasite density on the success of infection.

Authors:  Anna Paziewska-Harris; Martin Singer; Gerard Schoone; Henk Schallig
Journal:  Parasitol Res       Date:  2015-10-05       Impact factor: 2.289

Review 2.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

3.  Two- and Three-Dimensional Bioengineered Human Intestinal Tissue Models for Cryptosporidium.

Authors:  Daviel Cardenas; Seema Bhalchandra; Hymlaire Lamisere; Ying Chen; Xi-Lei Zeng; Sasirekha Ramani; Umesh C Karandikar; David L Kaplan; Mary K Estes; Honorine D Ward
Journal:  Methods Mol Biol       Date:  2020

4.  Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum.

Authors:  Maria A DeCicco RePass; Ying Chen; Yinan Lin; Wenda Zhou; David L Kaplan; Honorine D Ward
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

5.  Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis.

Authors:  Siyi Ni; Yingchao Liu; Jihong Zhong; Yan Shen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  The Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated Proteoglycans.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

7.  Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward.

Authors:  Hayley Sparks; Gayatri Nair; Alejandro Castellanos-Gonzalez; A Clinton White
Journal:  Curr Trop Med Rep       Date:  2015-08-01

8.  Robotically handled whole-tissue culture system for the screening of oral drug formulations.

Authors:  Thomas von Erlach; Sarah Saxton; Yunhua Shi; Daniel Minahan; Daniel Reker; Farhad Javid; Young-Ah Lucy Lee; Carl Schoellhammer; Tina Esfandiary; Cody Cleveland; Lucas Booth; Jiaqi Lin; Hannah Levy; Sophie Blackburn; Alison Hayward; Robert Langer; Giovanni Traverso
Journal:  Nat Biomed Eng       Date:  2020-04-27       Impact factor: 25.671

Review 9.  The Stem Cell Revolution Revealing Protozoan Parasites' Secrets and Paving the Way towards Vaccine Development.

Authors:  Alena Pance
Journal:  Vaccines (Basel)       Date:  2021-01-31

Review 10.  Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.

Authors:  Yukiko Miyamoto; Lars Eckmann
Journal:  Front Microbiol       Date:  2015-11-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.